Atazanavir

Therapeutic indications

Atazanavir is indicated for:

HIV-1 infection

Population group: both men and women, only adults (18 - 65 years old)

Atazanavir, co-administered with low dose ritonavir, is indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 300 mg once with ritonavir 100 mg daily

HIV-1 infection

Population group: both men and women, only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Atazanavir, co-administered with low dose ritonavir, is indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 200-300 mg once with ritonavir 100 mg daily

Contraindications

Atazanavir is contraindicated in the following cases:

Glecaprevir, pibrentasvir

at least one of
Glecaprevir
Pibrentasvir

Severe hepatic insufficiency

Hepatic failure stage IV

Ritonavir in moderate hepatic insufficiency

Ritonavir and additionally
Hepatic failure stage III

Simvastatin, lovastatin

at least one of
Simvastatin
Lovastatin

Rifampicin

Rifampicin

Sildenafil in pulmonary arterial hypertension (PAH)

Sildenafil

CYP3A4 substrates

CYP3A4 substrates

Grazoprevir, elbasvir, glecaprevir, pibrentasvir

at least one of
Grazoprevir
Elbasvir
Glecaprevir
Pibrentasvir

St. John's wort (Hypericum perforatum)

Hypericum perforatum (St John's Wort)

Quetiapine

Quetiapine

Lurasidone

Lurasidone

Alfuzosin

Alfuzosin

Quinidine

Quinidine

Bepridil

Bepridil

Midazolam, triazolam

at least one of
Midazolam
Triazolam

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: REYATAZ Hard capsules
< Previous: Overview
Next: Precautions >